London, United Kingdom · Founded 2017 · Privately Held (backing)
Developer of a cancer detection platform intended to detect cancer at the curable stage. C the Signs is based in London, United Kingdom and was founded in 2017. Its last reported valuation was $31.8 million in Feb 2022. It has raised $21 million.
Last reported valuation
$31.8M
Oct 2026
Priced at
—
Total raised
$21.0M
Last round
—
Cap table — not yet on record
C the Signs's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of C the Signs with a free account
·The complete investor list: 15 names
·Watch C the Signs: the Monday email on marks, rounds and moves
